Arsani William serves as Executive at Design Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Arsani William has executed 13 insider transactions totaling $40.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 13, 2025 involved selling 345,000 shares valued at $1.8M.
Arsani William currently holds 2,655,000 shares of Design Therapeutics, Inc. (DSGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arsani William has been a net buyer of DSGN stock. They have purchased $34.5M and sold $6.4M worth of shares.
Arsani William's most recent insider trade was on Aug 13, 2025, when they sold 345,000 shares at $5.25 per share.
Get notified when new Form 4 filings are submitted
| $5.25 |
| Discretionary |
| Aug 9, 2024 | DSGN | $3.5M | Sale | 814,874 | $4.25 | Discretionary |
| Aug 29, 2023 | DSGN | $4.8M | Purchase | 1,960,000 | $2.44 | Discretionary |
| Aug 28, 2023 | DSGN | $591.3K | Purchase | 275,000 | $2.15 | Discretionary |
| Mar 21, 2022 | DSGN | $474.8K | Purchase | 25,000 | $18.99 | Discretionary |
| Aug 31, 2021 | DSGN | $618.0K | Purchase | 40,000 | $15.45 | Discretionary |
| Mar 30, 2021 | DSGN | $14.0M | Purchase | 700,000 | $20.00 | Discretionary |
| Mar 30, 2021 | DSGN | $0 | Conversion | 814,874 | $N/A | Discretionary |
| Mar 30, 2021 | DSGN | $0 | Conversion | 1,217,627 | $N/A | Discretionary |
| Mar 30, 2021 | DSGN | $0 | Conversion | 814,874 | $N/A | Discretionary |
| Mar 30, 2021 | DSGN | $14.0M | Purchase | 700,000 | $20.00 | Discretionary |
| Mar 30, 2021 | DSGN | $0 | Conversion | 1,217,627 | $N/A | Discretionary |